← Leaderboards
Jianqin Lu
University Of Arizona
$2,521,145
Attributed
$2,521,145
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $721.2K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,521,145 · 2
By mechanism
R35$1,504,604 · 1
R01$1,016,541 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- Thomas P Miller$4,044,154
- W Daniel Stamer$14,957,526
- Jonathan H Schatz$2,947,463
Others in their field
Other Rising Stars on “Treatment Efficacy”
- Angee Greer · Ppd Development Lp$82,531,927
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Sabrina Paganoni · Massachusetts General Hospital$26,348,733
- Suma Babu · Massachusetts General Hospital$26,348,733
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Chris Maxwell · National Institute Of Allergy And Infectious Diseases$12,000,000
Research focus
Treatment EfficacyClinicPharmaceutical PreparationsTissuesDrug KineticsMediatingLiposomesNanotherapeuticSystemic ToxicityTherapeutic AgentsUptakeTechnologyPhospholipidsStructure-Activity RelationshipLipid BilayersChargeFortificationExtravasationBreast Cancer ModelAffectBlood CirculationEnvironmentExtracellular MatrixFuture
Grant awards (7)
A fortified lipid bilayer platform for improved drug packaging and therapeutic delivery$376,151
R35 · FY2025 · GM · contact PI
A Phospholipid-Derived Nanotherapeutic Platform for Improved Colorectal Cancer Immunochemotherapy$344,080
R01 · FY2025 · CA · contact PI
A fortified lipid bilayer platform for improved drug packaging and therapeutic delivery$376,151
R35 · FY2024 · GM · contact PI
A Phospholipid-Derived Nanotherapeutic Platform for Improved Colorectal Cancer Immunochemotherapy$327,374
R01 · FY2024 · CA · contact PI
A fortified lipid bilayer platform for improved drug packaging and therapeutic delivery$376,151
R35 · FY2023 · GM · contact PI
A Phospholipid-Derived Nanotherapeutic Platform for Improved Colorectal Cancer Immunochemotherapy$345,087
R01 · FY2023 · CA · contact PI
A fortified lipid bilayer platform for improved drug packaging and therapeutic delivery$376,151
R35 · FY2022 · GM · contact PI